Adjuvant chemotherapy with mFOLFOXIRI versus mFOLFOX6 in MRD-positive stage II-III colorectal cancer

被引：0
|
作者：
Zhang, Jianwei
Hu, Huabin
Cai, Yue
Xie, Xiaoyu
Wu, Zehua
Ling, Jiayu
Chen, Dianke
Liu, Ping
Kang, Liang
Deng, Yanhong
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Med Oncol, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou, Peoples R China
[3] Kunming Med Univ, Affiliated Hosp 3, Kunming, Yunnan, Peoples R China
[4] Sun Yat Sen Univ, Dept Colorectal Surg, Affiliated Hosp 6, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS3642
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Adjuvant chemotherapy for stage III colorectal cancer in the elderly
    Brungs, D.
    Healey, E.
    Rose, J.
    Tubaro, T.
    Ng, W.
    Chua, W.
    Carolan, M.
    de Souza, P.
    Aghmesheh, M.
    Ranson, M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [32] Adjuvant Chemotherapy With UFT/LV Versus UFT/LV Plus PSK in Stage II/III Colorectal Cancer
    Ogawa, Hiroomi
    Shiraishi, Takuya
    Okada, Takuhisa
    Miyamae, Yohei
    Motegi, Yoko
    Shirabe, Ken
    Saeki, Hiroshi
    ANTICANCER RESEARCH, 2024, 44 (02) : 805 - 814
  • [33] Phase II trial of adjuvant mFOLFOX6 after metastasectomy for pulmonary metastasis of colorectal cancer: WJOG5810G.
    Machida, Nozomu
    Okumura, Takehiro
    Kishimoto, Junji
    Boku, Narikazu
    Nishina, Tomohiro
    Suyama, Koichi
    Ohde, Yasuhisa
    Shinozaki, Katsunori
    Baba, Hideo
    Tokunaga, Shinya
    Kawakami, Hisato
    Tsuda, Takashi
    Kotaka, Masahito
    Okuda, Hiroyuki
    Yasui, Hisateru
    Denda, Tadamichi
    Yamazaki, Kentaro
    Hironaka, Shuichi
    Muro, Kei
    Hyodo, Ichinosuke
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [34] Is adjuvant chemotherapy beneficial for stage II-III goblet cell tumors of the appendix?
    Zakka, Katerina Mary
    Williamson, Shayla
    Jiang, Renjian
    Alese, Olatunji B.
    Shaib, Walid Labib
    Wu, Christina
    Behera, Madhusmita
    El-Rayes, Bassel F.
    Akce, Mehmet
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [35] Improved disease-free survival with intraportal chemotherapy plus adjuvant chemotherapy (mFOLFOX6) as adjuvant treatment in colon cancer.
    Chang, Wenju
    Xu, Jianmin
    Wei, Ye
    Ren, Li
    Liu, Tianshu
    Chen, Jingwen
    Zhu, Dexiang
    Lin, Qi
    Qin, Xinyu
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [36] A phase I/II, open-label, randomised study of nintedanib plus mFOLFOX6 versus bevacizumab plus mFOLFOX6 in first-line metastatic colorectal cancer patients
    Van Cutsem, E.
    Prenen, H.
    D'Haens, G.
    Bennouna, J.
    Carrato, A.
    Ducreux, M.
    Bouche, O.
    Sobrero, A.
    Latini, L.
    Staines, H.
    Oum'Hamed, Z.
    Dressler, H.
    Studeny, M.
    Capdevila, J.
    ANNALS OF ONCOLOGY, 2015, 26 (10) : 2085 - 2091
  • [37] Microsatellite instability and oral fluoropyrimidine adjuvant chemotherapy in stage II and III colorectal cancer
    Kakeji, Y.
    Oki, E.
    Ohgaki, K.
    Shibahara, K.
    Shiotani, S.
    Sadanaga, N.
    Morita, M.
    Maehara, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [38] MERMAID-1: A Phase III Study on adjuvant Therapy with Durvalumab plus Chemotherapy in resected and postoperative MRD-positive (MRD +) NSCLC-Patients
    Reinmuth, N.
    Peters, S.
    PNEUMOLOGIE, 2021, 75 : S11 - S12
  • [39] Adjuvant therapy for stage II and III colorectal cancer
    de Gramont, Aimery
    Tournigand, Christophe
    Andre, Thierry
    Larsen, Annette K.
    Louvet, Christophe
    SEMINARS IN ONCOLOGY, 2007, 34 (02) : S37 - S40
  • [40] A phase II study of pembrolizumab in combination with mFOLFOX6 for patients with advanced colorectal cancer.
    Shanda, Safi
    Noonan, Anne M.
    Bekaii-Saab, Tanios S.
    O'Neil, Bert H.
    Sehdev, Amikar
    Shaib, Walid Labib
    Helft, Paul R.
    Loehrer, Patrick J.
    Tong, Yan
    Liu, Ziyue
    El-Rayes, Bassel F.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345